OHSU

Clinical Investigational Agents Consisting of Recombinant DNA or Infectious Agents

Description

This Health Care Systems policy details the requirements for all investigational gene therapy agents or infectious agents that will be introduced into human subjects as part of a research protocol.


View Policy and Procedure 


About this Policy

Program: Institutional Biosafety Committee
Type: IBC Policies

 

QUICK LINKS

Policies & Forms by Program

 Institutional Integrity Policies & Forms

 COI-125-x75

IPS-125-x75

 EHRS Policies

 Healthcare Integrity Forms & Policies

 IACUC Policies

 IBC Policies

 IRB Policies & Forms